Atlas Trials

Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy

Clinical trial NCT03418324 · COMPLETED

Trial details

NCT number
NCT03418324
Sponsor
Cedars-Sinai Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2018-03-05
Primary completion
2019-11-06
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.